Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 [email protected].
-
Upload
stanley-mckinney -
Category
Documents
-
view
221 -
download
1
Transcript of Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 [email protected].
![Page 2: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/2.jpg)
Mucosal Immunity & Infections
• Balancing act– Tolerate commensals, food antigens– Protect against infectious agents
• Gut is most frequent site of infection against pathogenic bugs
• Emerging themes: Th17 cells in the mucosa
![Page 3: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/3.jpg)
![Page 4: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/4.jpg)
![Page 5: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/5.jpg)
Mucosal pathogens exploit mucosal surfaces
• Enteric pathogens often enter via M cells– Salmonella – typhoid, food poisoning– Shigellae – dysentery– Yersiniae – plague
![Page 6: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/6.jpg)
![Page 7: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/7.jpg)
Oral Tolerance
• Oral tolerance is – A general immunosuppressive state in the oral
mucosa to prevent reaction to harmless Ags such as commensals or foods
– the generation of systemic immune unresponsiveness by feeding of antigen
• Necessary to prevent excessive response to normal flora and food antigens
![Page 8: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/8.jpg)
![Page 9: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/9.jpg)
A modern version of the same experiment:
o Mice are given naïve CD4+ T cells that transgenically express TCR specific for OVA peptide (OT-II mice)
o Mice are fed ovalbumin
o After tolerance induction, OVA-T cells are anergized - they do not proliferateto OVA/adjuvant in vitro.
o Smaller numbers of OVA-specific T cells suggest clonal deletion
Experiment to demonstrate Oral Tolerance
![Page 10: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/10.jpg)
Limitations to Oral Tolerance
• Can be overcome with mucosal adjuvant (e.g. Cholera toxin)
• Alter physical characteristics of antigen: antigen in micro-spheres that target PP
• Feeding of attenuated enteric pathogen expressing the antigen (Salmonella)
![Page 11: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/11.jpg)
Commensals• They outnumber us at least 10-100:1 (“you are only
1-10% human”)• Weight ~1 kg• Normal commensal flora maintain health
– Help metabolize cellulose, etc.– Fill niches to prevent pathogenic bacteria from colonizing– Required for immune development: germ-free rodents
have reduced lymphoid organs, low Ig, reduced immune responses of all types
– Help maintain tolerance
![Page 12: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/12.jpg)
![Page 13: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/13.jpg)
Commensals are immunosuppressive• Different microbiota in disease vs health• Intestinal epithelial cells play role in regulating response to
commensals– IECs deficient in SIGGIR (negative regulator of TLRs) show
increased cytokines, increased susceptibility to intestinal inflammation
• Immune status of host also influences makeup of commensal flora, thereby affecting immune system function– IgA-deficient mice have different microbial spp– Tbet KO/scid mice have increased “colitogenic” bacteria and UC
symptoms
![Page 14: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/14.jpg)
![Page 15: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/15.jpg)
Specific commensals determine inflammation vs. suppression
• Differentiation of lamina propria T cells into Treg vs Th17 cells is determined by flora– Bacterial DNA signals through TLR9 to suppress
Treg conversion, acts as a “natural adjuvant” (Hall, Immunity 2008)
– Specific types of flora promote Th17 vs Treg development in the intestine (Ivanov, Cell Host & Microbe, 2008)
![Page 16: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/16.jpg)
![Page 17: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/17.jpg)
Commensals & Pathogens influence NF-kB
Artis, Nat Rev Immunol 2008
![Page 18: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/18.jpg)
Examples of mucosal diseases- role for Th17 cells
• Gut: IBD – autoimmune diseases of the gut• Vaginal mucosa:Th17 cells are protective against
Neisseria gonnorrheae• Lung: Th17 cells are protective against various
pneumoniaes, TB, etc., promote airway hyperreactivity/allergy
• Mouth: Th17 cells promote Sjogren’s (autoimmune disease of salivary gland, tear ducts), but protective in oropharyngeal candidiasis (“thrush”)
![Page 19: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/19.jpg)
The Spectrum of Inflammatory Bowel Disease
Ulcerative colitis Crohn’s disease
![Page 20: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/20.jpg)
IBD: Evidence of Genetic Influence
• Racial differences in incidence:White > Black > Asian
• Ethnic influences:Jewish > non-Jewish; Ashkanazi > Sephardic
• Twin studies: Monozygotic > dizygotic
• Association with specific HLA antigens
• Genes
– NOD2, IL-23RSartor RB. Inflammatory Bowel Dis. 1995;24:475.
![Page 21: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/21.jpg)
NOD2• First identified Crohn’s disease
susceptibility gene.• Chromosome 16q12.• One frameshift mutation (Europe and USA)
and 2 point mutations (Europe) identified.• Allele frequency 8.2% in CD, 4.0% in
controls, 3.2% in UC.
Ougura et al; Nature 2001; 411: 603Hugot et al; Nature 2001; 411: 599
![Page 22: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/22.jpg)
IL23R
ATG16L1
3p21
5p13
IBD5
IRGM 10q21 NKX2-3
NOD2
PTPN2MHC
SBNO2
5q33
![Page 23: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/23.jpg)
Innate Mucosal defenses- Pattern Recognition Receptors
• TLRs – Toll-like receptors– Bind LPS, flagellin, bacterial (CpG) DNA, dsRNA, etc.– “extracellular” pattern recognition
• NLRs – NOD-like receptors– Bind muramyl di- and tri-peptides (from LPS)– “intracellular” pattern recognition
• C-type lectin receptors– Dectins– Clec’s
![Page 24: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/24.jpg)
Kawai and Akira (2006) Cell Death and Differentiation
![Page 25: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/25.jpg)
![Page 26: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/26.jpg)
NODs complement function of TLRs
• NODs (nucleotide-binding oligomerization domain) recognize microbial components found in cytosol
• NODS are intracellular pattern recognition receptors• NODs bind peptidoglycan in bacterial cell walls• NODs lead to activation of Caspase-1, cleavage of inactive
forms of IL-1 (and other related cytokines)• NODs can also downregulate immune responses• Mutations in NOD genes associated with Crohn’s disease,
inflammatory bowel disease, asthma
![Page 27: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/27.jpg)
NLRs
![Page 28: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/28.jpg)
“Loss of Function” Mutations in NOD2
• How could this lead to IBD?– Bacterial products from commensal flora deliver
anti-inflammatory signals through NOD2– Intracellular defect in LPS signaling (NOD2) may
lead to increased extracellular signaling (TLRs)– Decreased apoptosis of bacterially activated cells– Defective killing of bacteria leading to persistent
immune response– Maeda et al, Science 2005
![Page 29: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/29.jpg)
Local Environmental Factors in IBD
• Germ-free-derived colitis-prone animals do not develop IBD unless commensal enteric bacteria are re-introduced
• Restriction of bacterial colonization reduces the incidence of IBD
• Antibiotic administration reduces the incidence of IBD
• Enteric bacterial antigens activate T cells and induce colitis
• A selected subset of bacterial proteins triggers immune reactions
• No specific bacterial or viral infection has been identified
![Page 30: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/30.jpg)
Cytokines in IBD
• Spontaneous IBD models– IL-10 -/-– IL-10R -/-– TGF -/-– IL-2 -/-– Transgenic TNF– IL-12p40-KO mice are resistant
• Long interpreted to mean that Th1 cells mediate pathology in IBD, CD
- anti-IL-12p40 used in humans to treat CD!
![Page 31: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/31.jpg)
Chronic Inflammation: Imbalance Between Mediators
Pro-inflammatoryPro-inflammatory
Anti-inflammatory
Anti-inflammatory
TNF-TNF-IL-1IL-1
IL-17IL-17IL-12/23IL-12/23
IFN-IFN-TGF-TGF-
IL-10IL-10
IL-1raIL-1raIL-4/IL-13IL-4/IL-13
![Page 32: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/32.jpg)
IL-10• Immunosuppressive cytokine
– Inhibits DC maturation– Inhibits TNF production by macrophages– Inhibits IL-12 production– Limits “collateral damage” in infection
• IL-10-KO mice have severe, spontaneous IBD• Produced by all Th subsets (not just Th2)• IL-23 inhibits IL-10 production in Th17 cells• O’Garra and Vieira, Nat Rev Immunol, June 2007
![Page 33: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/33.jpg)
Cytokines in IBD
• Spontaneous IBD models– IL-10 -/-– IL-10R -/-– TGF -/-– IL-2 -/-– Transgenic TNF– IL-12p40-KO mice are resistant
• Long interpreted to mean that Th1 cells mediate pathology in IBD, CD
- anti-IL-12p40 used in humans to treat CD!
![Page 34: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/34.jpg)
IL-17-producing T cellsTh1- IFN (Cell-mediated immunity)
IL-12p40/p35
Th2- IL-4, IL-5, IL-13 (Humoral immunity, allergy)
IL-4Thp
IL-2,TGF
Treg- IL-10, TGF(Immune Suppression)
Th17- IL-17, IL-17F, IL-21, IL-22, IL-26 (Inflammation, autoimmunity)
TGF+ IL-6, IL-1, IL-23 (p40/p19)
IL-23R
![Page 35: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/35.jpg)
IL-12 family of cytokines
![Page 36: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/36.jpg)
IL-23 rather than IL-12 per se in IBD
J. Clin. Invest. David Yen, et al. 116:1310 doi:10.1172/JCI21404
• IL-10KO– Strong disease
• IL-10KO x IL-12p35KO– Still get disease
• IL-10KO x IL-23p19KO– Protected from disease
![Page 37: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/37.jpg)
IL23R
ATG16L1
3p21
5p13
IBD5
IRGM 10q21 NKX2-3
NOD2
PTPN2MHC
SBNO2
5q33
![Page 38: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/38.jpg)
• Lactobacillus prevents colitis in mouse models of IBD; can inhibit NF-kB and hence inflammation
• E. coli as effective as mesalazine in remission maintenance in UC.
• Enteric helminths are anti-inflammatory; generate strong Th2 response (inhibits Th17?) (“eat worms!”)
• Epidemiologic data incidence of IBD increases with improved sanitation = “hygiene hypothesis” (more Th1 responses, inhibits Th17?)
Probiotics and IBD
![Page 39: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/39.jpg)
IL-17-producing T cellsTh1- IFN (Cell-mediated immunity)
IL-12p40/p35
Th2- IL-4, IL-5, IL-13 (Humoral immunity, allergy)
IL-4Thp
IL-2,TGF
Treg- IL-10, TGF(Immune Suppression)
Th17- IL-17, IL-17F, IL-21, IL-22, IL-26 (Inflammation, autoimmunity)
TGF+ IL-6, IL-1, IL-23 (p40/p19)
IL-23R
![Page 40: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/40.jpg)
Examples of mucosal diseases- role for Th17 cells
• Gut: IBD – autoimmune diseases of the gut• Vaginal mucosa:Th17 cells are protective against
Neisseria gonnorrheae• Lung: Th17 cells are protective against various
pneumoniaes, TB, etc., promote airway hyperreactivity/allergy
• Mouth: Th17 cells promote Sjogren’s (autoimmune disease of salivary gland, tear ducts), but protective in oropharyngeal candidiasis (“thrush”)
![Page 41: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/41.jpg)
Immunity in the oral mucosa:Lick your wounds
![Page 42: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/42.jpg)
Candida albicans
(Berman, 2002)
•Common fungal commensal of the human oral cavity
•Pathogenic when host immune response compromised
•HIV+•Cancer-radiation and chemotherapy•HIES (hyper-IgE syndrome)•Infants and elderly
•Progression from commensal state to pathogen is poorly understood
42
![Page 43: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/43.jpg)
CD4+ T cells
Immune Components:CD4+ T cells, neutrophils,
monocytes, macrophages, dendritic cells, T cells, mucosal epithelial cells, antimicrobial peptides,
cytokines
Systemic
Oropharyngeal candidiasis“OPC”
Vaginal
Mucocutaneous
CD4+ T cell are vital for protection against OPC
43
![Page 44: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/44.jpg)
IL-12
Th1
Thp
IL-23
IFN-
IL-17IL-17FIL-21IL-22
Cell-mediated Immunity
Intracellular bacteria,
protozoa, viruses
Acute InflammationAutoimmunityExtracellular
microbes
CD4+
CD4+
CD4+
Th2
CD4+IL-4
IL-4,5,13Humoral Immunity
Helminthes
Which CD4+ Th cell subset is involved in immunity to OPC?
44
![Page 45: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/45.jpg)
p40
p35
Th1 vs. Th17
p40
p19
IL-12Th1
IL-23Th17
vs.
IL-12p35KO mice IL-23p19KO mice
45
![Page 46: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/46.jpg)
Immunity to OPC• Long considered to be Th1-dependent
– IL-12p40KO (Th1-deficient) mice are susceptible– IL-4KO (Th2-deficient) mice are resistant
• BUT…– IFNKO mice (Th1-deficient) are resistant– IL-12p40 is part of IL-23 (therefore, Th1 and Th17-deficient)
• AND …– IL-17RAKO mice are susceptible to disseminated candidiasis– IL-17 and IL-23 drive pathogenesis in gastric candidiasis
• SO… What is the role of Th17 cells in OPC?
46
![Page 47: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/47.jpg)
Experimental Mouse Model of OPC
Day: -1 0 1 2 3 4 5 6 7
Cortisone Cortisone Cortisone
Infection
Monitor weight, appearance, activity level, etc.
Sac micecollect blood,LN, spleen,
tongue
Tongue-YPDAgar plates
Colony Count
Mean: 3 6.4X105 47
![Page 48: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/48.jpg)
Th17-deficient mice are more susceptible to OPC than Th1-deficient mice
Conclusion:Th17 cells, not Th1 cells, are essential for mucosal host
defense against oral candidiasis
48
![Page 49: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/49.jpg)
Th17-deficient mice are more susceptible to OPC than Th1-deficient mice
IL-23KO + CandidaIL-12KO + Candida
49
WT-No Cort, Sham
![Page 50: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/50.jpg)
Th17 cells control PMNs, anti-microbial defenses
(Kolls et al, Nature Reviews Immunology Nov 2008) 50
![Page 51: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/51.jpg)
Host defense against oral C. albicans is mediated mainly by -T cells, rather than -T cells
51
![Page 52: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/52.jpg)
Affymetrix GeneChip Mouse Genome 430 2.0 Array analysis of tongue tissue
Comparisons:WT Day 0 vs. WT Day 1IL-17RAKO Day 0 vs. IL-17RAKO Day 1WT Day 0 vs. IL-17RAKO Day 0WT Day 1 vs. IL-17RAKO Day 1
Day: -1 0 1 2 3 4 5 6 7
Cortisone Cortisone Cortisone
Infection
Monitor weight, appearance, activity level
Sac micecollect blood,LN, spleen, tongue, etc.
Tongue-YPDAgar plates
Colony Count
Microarray Microarray
52
![Page 53: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/53.jpg)
IL-17 induces expression of antimicrobial proteins
-defensin 3 (BD3, DEFB3)• small inducible cationic protein expressed by salivary gland and
epithelial cells• Interacts with CCR6• Exerts potent candidacidal activity in vitro• Induced by IL-17 and IL-22 in the gut and lungs
53
![Page 54: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/54.jpg)
Anti-microbial peptides
• Small, cationic peptides (6-60 a.a.) typically found in mucosal surfaces and skin, can directly kill microbes
• Found in frogs, flies, humans, plants, etc.• Regulated by TLRs, NODs, inflammation• Often work by disrupting target membranes,
mechanisms not full known
![Page 55: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/55.jpg)
![Page 56: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/56.jpg)
IL-17RAKO mice show decreased expression of mBD3
(Experiment performed in collaboration with Jianing Sun)56
![Page 57: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/57.jpg)
IL-23 and IL-17, not IL-12, regulate the antimicrobial activity of saliva
(Experiment performed in collaboration with Namrata Nayyar)
+ carbachol
+
Add Candida (104 cells)
Incubate 1 hour, 37°C
Plate 500 cells on YPD agar
Count colonies 48 hours later 57
![Page 58: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/58.jpg)
Hyper-IgE syndromeHIES or ‘Job’s syndrome’
•Rare multi-system disorder (incidence <1/106) with immunologic and non-immunologic features:
•Extremely elevated serum IgE
•Staphylococcal abscesses
•Mucocutaneous and oral candidiasis
•Bone and connective tissue abnormalities
•Characteristic facial features (prominent forehead, fleshy nasal tip)
•Pathological fractures
•Retention of primary teeth
•Lesions of hard palate and dorsal tongue 58
![Page 59: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/59.jpg)
Defective response to IL-6, IL-10, IL-2159
![Page 60: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/60.jpg)
Th1
ThpTh2
STAT1,4T-bet
STAT6GATA3
RORtSTAT3
Th cell subset defining transcription factors
60
![Page 61: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/61.jpg)
![Page 62: Mucosal Immunity Part 2 Sarah L. Gaffen Spring, 2009 sig65@pitt.edu.](https://reader036.fdocuments.net/reader036/viewer/2022062422/56649eb55503460f94bbeb17/html5/thumbnails/62.jpg)
Th17 cells/IL-17 receptor signaling and not Th1 cells are essential for host defense against OPC
Oral CavityAdapted from O’quinn et al. Advances in Immunonolgy Vol 99, 2008
62